Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.
Simpson GR, Horvath A, Annels NE, Pencavel T, Metcalf S, Seth R, Peschard P, Price T, Coffin RS, Mostafid H, Melcher AA, Harrington KJ, Pandha HS.
Br J Cancer. 2012 Jan 31;106(3):496-507. doi: 10.1038/bjc.2011.577. Epub 2012 Jan 12.
Related citations
Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.
Polesel J, Gheit T, Talamini R, Shahzad N, Lenardon O, Sylla B, La Vecchia C, Serraino D, Tommasino M, Franceschi S.
Br J Cancer. 2012 Jan 3;106(1):222-6. doi: 10.1038/bjc.2011.519. Epub 2011 Nov 24.
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, Gao S, Hansen TB, Jensen TI, Borre M, Ørntoft TF, Dyrskjøt L, Kjems J.
Br J Cancer. 2012 Jan 17;106(2):366-74. doi: 10.1038/bjc.2011.520. Epub 2011 Nov 22.
Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.
Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R, Trink B.
Br J Cancer. 2011 Oct 25;105(9):1295-301. doi: 10.1038/bjc.2011.386. Epub 2011 Oct 6.
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
Munksgaard PP, Mansilla F, Brems Eskildsen AS, Fristrup N, Birkenkamp-Demtröder K, Ulhøi BP, Borre M, Agerbæk M, Hermann GG, Orntoft TF, Dyrskjøt L.
Br J Cancer. 2011 Oct 25;105(9):1379-87. doi: 10.1038/bjc.2011.404. Epub 2011 Oct 6.
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.
Br J Cancer. 2011 Oct 25;105(9):1331-7. doi: 10.1038/bjc.2011.399. Epub 2011 Oct 4.
In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
Adhim Z, Matsuoka T, Bito T, Shigemura K, Lee KM, Kawabata M, Fujisawa M, Nibu K, Shirakawa T.
Br J Cancer. 2011 Jul 26;105(3):393-402. doi: 10.1038/bjc.2011.262. Epub 2011 Jul 12.
Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.
Pridgeon SW, Heer R, Taylor GA, Newell DR, O'Toole K, Robinson M, Xu YZ, Karran P, Boddy AV.
Br J Cancer. 2011 Jun 7;104(12):1869-76. doi: 10.1038/bjc.2011.180. Epub 2011 May 24.
Expression of NRG1 and its receptors in human bladder cancer.
Forster JA, Paul AB, Harnden P, Knowles MA.
Br J Cancer. 2011 Mar 29;104(7):1135-43. Epub 2011 Mar 1.
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M.
Br J Cancer. 2011 Mar 1;104(5):808-18. Epub 2011 Feb 8.
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
Lamont FR, Tomlinson DC, Cooper PA, Shnyder SD, Chester JD, Knowles MA.
Br J Cancer. 2011 Jan 4;104(1):75-82. Epub 2010 Nov 30.
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.
Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S, Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
Br J Cancer. 2011 Jan 18;104(2):376-86. Epub 2010 Nov 9.
Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
Wu CF, Ng KF, Chen CS, Chang PL, Chuang CK, Weng WH, Liao SK, Pang ST.
Br J Cancer. 2010 Sep 7;103(6):852-60. Epub 2010 Aug 24.
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M.
Br J Cancer. 2010 Mar 2;102(5):883-91. Epub 2010 Feb 16.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on